The benefits with Pandemrix are that it can mount an appropriate immune response in individuals that are immunologically naive against the mock-up vaccine strain. It is an adjuvanted vaccine that induces an immune response (circulating antibodies) against the H5N1 antigen. This vaccine will only be used in an officially declared influenza pandemic and after inclusion of the exact matching pandemic influenza vaccine strain into the vaccine.